Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2015

Conditions
Arthritis, Psoriatic
Interventions
BIOLOGICAL

Placebo matching BMS-945429

Injection, Subcutaneous, 0 mg, every 4 weeks, Short term:24 weeks, Long term: After 24 Wk, selected dose, open-label

BIOLOGICAL

BMS-945429

Injection, Subcutaneous, 25 mg, every 4 weeks, Short term:24 weeks, Long term: After 24 Wk, selected dose, open-label

BIOLOGICAL

BMS-945429

Injection, Subcutaneous, 100 mg, every 4 weeks, Short term:24 weeks, Long term: After 24 Wk, selected dose, open-label

BIOLOGICAL

BMS-945429

Injection, Subcutaneous, 200 mg, every 4 weeks, Short term:24 weeks, Long term: After 24 Wk, selected dose, open-label

Trial Locations (49)

1015

Local Institution, Capital Federal

1023

Local Institution, Budapest

1062

Local Institution, Budapest

1425

Local Institution, Capital Federal

1428

Local Institution, Capital Federal

4000

Local Institution, San Miguel de Tucumán

4001

Local Institution, Durban

4012

Local Institution, Debrecen

4558

Local Institution, Maroochydore

4870

Local Institution, Cairns

5011

Local Institution, Woodville

6008

Local Institution, Shenton Park

7405

Local Institution, Pinelands, Cape Town

7500

Local Institution, Panorama, Cape Town

8200

Local Institution, Veszprém

15006

Local Institution, A Coruña

18015

East Penn Rheumatology Associates, P.C., Bethlehem

20127

Local Institution, México

28210

Box Arthritis And Rheumatology Of The Carolinas, Pllc, Charlotte

34239

Sarasota Arthritis Research Center, Sarasota

39202

Arthritis Associates Of Mississippi, Jackson

41071

Local Institution, Seville

45190

Local Institution, Zapopan

50139

Local Institution, Florence

60773

Local Institution, Poznan

61231

Local Institution, Bad Nauheim

64460

Local Institution, Monterrey

73103

Health Research Of Oklahoma, Oklahoma City

80131

Local Institution, Napoli

80230

Denver Arthritis Clinic, Denver

82152

Local Institution, Planegg

91054

Local Institution, Erlangen

92108

San Diego Arthritis Medical Clinic, San Diego

115522

Local Institution, Moscow

150003

Local Institution, Yaroslavl

06611

New England Research Associates, Llc, Trumbull

R3A 1M3

Manitoba Clinic, Winnipeg

H2L 1S6

Local Institution, Montreal

G5L 8W1

Centre De Rhumatologie De L Est Du Quebec, Rimouski

G8Z 1Y2

Centre De Recherche Musculo-Squelettique, Trois-Rivières

530 02

Local Institution, Pardubice

128 50

Local Institution, Prague

15-351

Local Institution, Bialystok

62-069

Local Institution, Dąbrówka

82-300

Local Institution, Elblag

01-868

Local Institution, Warsaw

0083

Local Institution, Pretoria

0084

Local Institution, Pretoria

08036

Local Institution, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY